Merck & Co., Inc.
No trades
No trades
Peers for comparison
15.54 B EUR
55.28 B EUR
2.46 B
Last report date
—
Report period
—
EPS
—
Revenue
—
Earnings release details
Q3 revenue rose 5% to $18.1B, with new products and oncology and animal health strength. 2026 guidance midpoint increased; 2027 is expected to bring moderate growth amid >$2B of generic and LOE headwinds and continued investment.
Company info
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
IPO date
Jan 1, 1941
ISIN
US58933Y1055
CUSIP
58933Y105
FIGI
BBG000G580D7
Identifiers
ISIN US58933Y1055
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck Significant Upside on the cardsMerck has made a Kiss of Love in True Strength Indicator 1Day Chart. 1Day Fisher Transform has made a Double Bottom. 1W Fisher is already up.
A significant rise is on the cards. It has also come out of TRIANGLE pattern at Bottom.
A Buy at current level.
Target - 1Day Fisher Top (Few weeks).
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateDec 4, 2065
Coupon5.70% (Fixed)
Maturity dateMay 17, 2063
Coupon5.15% (Fixed)
Maturity dateSep 15, 2055
Coupon5.70% (Fixed)
Maturity dateMar 7, 2049
Coupon4.00% (Fixed)
Maturity dateMay 22, 2056
Coupon5.85% (Fixed)
Maturity dateDec 4, 2055
Coupon5.55% (Fixed)
Maturity dateMay 17, 2053
Coupon5.00% (Fixed)
Maturity dateDec 10, 2061
Coupon2.90% (Fixed)
Maturity dateMay 22, 2046
Coupon5.75% (Fixed)
Maturity dateDec 10, 2051
Coupon2.75% (Fixed)
Maturity dateMar 15, 2046
Coupon5.50% (Fixed)
See all 6MK bonds
Frequently asked questions
Today, 6MK trades at 133.16 EUR.
For broader market analysis, dive into the technicals on the Merck & Co., Inc. stock price chart and read the latest 6MK news:
– China Cranks Out New Drugs. How to Play It. — Barron's
– Wisconsin reports measles-linked infant death as U.S. cases top 5,000
– Democratic lawmakers seen probing Trump drug pricing deals come January
For broader market analysis, dive into the technicals on the Merck & Co., Inc. stock price chart and read the latest 6MK news:
– China Cranks Out New Drugs. How to Play It. — Barron's
– Wisconsin reports measles-linked infant death as U.S. cases top 5,000
– Democratic lawmakers seen probing Trump drug pricing deals come January
Markets don't sleep, here's what's going on with 6MK at the moment:
– China Cranks Out New Drugs. How to Play It. — Barron's
– Wisconsin reports measles-linked infant death as U.S. cases top 5,000
– Democratic lawmakers seen probing Trump drug pricing deals come January
See more updates in real-time with our News Flow.
– China Cranks Out New Drugs. How to Play It. — Barron's
– Wisconsin reports measles-linked infant death as U.S. cases top 5,000
– Democratic lawmakers seen probing Trump drug pricing deals come January
See more updates in real-time with our News Flow.
Merck & Co., Inc. is scheduled to release its next earnings report on Feb 2, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
6MK stock is 2.75% volatile and has beta coefficient of 0.29.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 6MK are typically less volatile than smaller companies
Track every detail on Merck & Co., Inc. stock chart and check out the list of the most volatile stocks — is Merck & Co., Inc. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 6MK are typically less volatile than smaller companies
Track every detail on Merck & Co., Inc. stock chart and check out the list of the most volatile stocks — is Merck & Co., Inc. there?
To understand the 6MK stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −2.22%
– 1 week — −2.10%
– 1 month — +2.78%
6MK all-time low was 20.56 EUR (Aug 9, 2011), and its highest price is 136.44 EUR (Oct 22, 2026). Find more dynamics in the Stock Heatmap and on the Merck & Co., Inc. stock chart.
– 1 day — −2.22%
– 1 week — −2.10%
– 1 month — +2.78%
6MK all-time low was 20.56 EUR (Aug 9, 2011), and its highest price is 136.44 EUR (Oct 22, 2026). Find more dynamics in the Stock Heatmap and on the Merck & Co., Inc. stock chart.
Merck & Co., Inc. market capitalization is 324.68 B, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Merck & Co., Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Merck & Co., Inc. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Merck & Co., Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Merck & Co., Inc. stacks up against other companies
The safest way to buy Merck & Co., Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade 6MK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade 6MK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 9, 2026, the company has 75 K employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Merck & Co., Inc. pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.
Its recent dividend yield was around 3.12%, with a payout ratio of 45.05%, compared to 3.14% and 46.32% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in Merck & Co., Inc. financials.
Its recent dividend yield was around 3.12%, with a payout ratio of 45.05%, compared to 3.14% and 46.32% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in Merck & Co., Inc. financials.
Investing in Merck & Co., Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Merck & Co., Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our 6MK technicals – signals based on essential indicators calculations:
– Today — strong buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
First, study Merck & Co., Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our 6MK technicals – signals based on essential indicators calculations:
– Today — strong buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
Merck & Co., Inc. stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, Merck & Co., Inc. stocks trade under the symbol MRK.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
6MK earnings for the last quarter are 2.20 EUR per share, whereas the estimation was 1.84 EUR, resulting in a 19.40% surprise. The estimated earnings for the next quarter are 1.58 EUR per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Merck & Co., Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Merck & Co., Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Merck & Co., Inc. revenue for the last quarter amounts to 15.96 B EUR despite the estimated figure of 15.30 B EUR. In the next quarter revenue is expected to reach 14.62 B EUR.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Merck & Co., Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Merck & Co., Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Merck & Co., Inc. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
6MK net income for the last quarter is 4.47 B EUR, while the quarter before that showed −1.17 B EUR of net income which accounts for 482.49% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Merck & Co., Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Merck & Co., Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
Merck & Co., Inc. does pay dividends, which are distributed quarterly. The most recent dividend per share was 0.74 EUR, with a trailing twelve-month (TTM) dividend yield of 2.32%.
Explore more details on Merck & Co., Inc. dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
Explore more details on Merck & Co., Inc. dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
6MK reached its all-time high of 136.44 EUR on Oct 22, 2026. Its all-time low was 20.56 EUR and was reached on Aug 9, 2011.
Explore the Merck & Co., Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Merck & Co., Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 93.52 EUR and 165.66 EUR for 6MK, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance




